Structural Cardiac disease is a non-coronary defect of the heart, thus not affecting the blood vessels in the heart. Most of the structural heart conditions are present since birth (congenital), but these can also be acquired later in life, owing to wear & tear from infection. Advancements in the medical field have replaced the open heart surgical procedures with minimally invasive procedures, such as transcatheter aortic valve replacement (TAVR) and transcatheter mitral valve repair (TMVR).
MARKET SCOPE
The Structural Cardiac Implant Market is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Structural Cardiac Implant Market with detailed market segmentation by type, , end-user, and geography. The report provides key statistics on the market status of the leading Structural Cardiac Implant Market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
- Based on type, the Structural Cardiac Implant Market is segmented into
I. Heart Valves & Accessories
II. Tissue Heart Valves
III. Mechanical Heart Valves
IV. Heart Valve Repair Devices
V. Ventricular-Assist Devices
VI. Implantable Heart Monitors
VII. Insertable Loop Recorders (ILRs)
VIII. Implantable Hemodynamic Monitors (IHMs)
- By end-user, the market is segmented into Hospitals, Ambulatory Settings, and Clinics.
MARKET DYNAMICS
Drivers:
- The rise in the incidence of structural heart diseases (aortic stenosis and mitral regurgitation).
- Technological advancements in the structural heart devices industry.
- Development of innovative repair devices.
- Increase in demand for minimally invasive.
- The high cost of surgeries and stringent government regulations hamper the growth.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East & Africa (MEA), and South And Central America. The Structural Cardiac Implant Market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both the demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South And Central America after evaluating political, economic, social and technological factors affecting the Structural Cardiac Implant Market in these regions.
IMPACT OF COVID-19 ON STRUCTURAL CARDIAC IMPLANT MARKET
COVID-19 first began in Wuhan (China) in December 2019, and since then, it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, UK, Turkey, Italy, and Spain are some of the worst affected countries in terms of confirmed cases and reported deaths. The pandemic has affected the growth of this market worldwide due to the business shutdown, worldwide lockdown, and supply and trade disruptions. While the situation is rapidly evolving, the pandemic had already disrupted the world in three ways the direct health impact the impact on the healthcare system, and the social and economic consequences of the pandemic. The structural heart devices market outlook has been seriously affected by the global outbreak of COVID-19 as it led to a temporary delay in the surgical procedures that were not an emergency. This was majorly due to the high risk of infection in the healthcare settings that could possibly affect patients with heart-related disorders. However, with the increasing adoption of safety measures across hospitals coupled with the growing necessity for surgical procedures, the structural heart devices market is expected to grow steadily over the subsequent years.
MARKET PLAYERS
The report covers key developments in the Structural Cardiac Implant Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals, and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, partnerships & collaborations. These activities have paved the way for the expansion of the business and customer base of market players. The market players from the Structural Cardiac Implant Market are anticipated to have lucrative growth opportunities in the future with the rising demand for Structural Cardiac Implant Market in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Structural Cardiac Implant Market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- Stryker Corporation
- Synthes
- Boston Scientific
- Zimmer Biomet
- Smith & Nephew
- Medtronic
- Abbott
- Tornier
- LivaNova Plc.
- Lepu Medical